ISoP Data Standards Draft Document - Population Pharmacokinetic Data Standard - review extended until 31-Jan

Dear Colleagues, Many thanks to everyone who has participated in the review of the draft for population PK data standard, sponsored by ISoP's Standards and Best Practices Committee. We have received lots of great comments and there have been a request to extend the review, as the year-end kept many people quite busy. Therefore, if you wish to contribute, please do so by 31-Jan-2018 using "Suggesting" mode (top right-hand corner of the Google Docs interface). https://urldefense.proofpoint.com/v2/url?u=https-3A__docs.google.com_document_d_1MUGiU6U-2D52pw-5FnojPD5lNR9PrTxoEeM3IQFLWeDOM6A_edit-3Fusp-3Dsharing&d=DwMFaQ&c=ZbgFmJjg4pdtrnL2HUJUDw&r=mS8o80zY_amVkf1tPfjwJooaDw3Wi4LREYW3mgf4EPza__UFGeQmeuHQrtl_2pdl&mAX3HQa9qNK0vf9uGUvKi5gl7hK2BsYsog1jykiIX4&s=AzzHiDUEWjSphpVvaJoLtJ4Ydptc-Q42Rce8xnakbkI&e= We also opened up a document to keep track of your suggestions and address them as we take them into account. https://docs.google.com/document/d/1yIA6ZSHoY60GqMx3YzMv4bmiMJ36vyFtQ3ABBpT8Xxk/edit?usp=sharing Thanks very much! Best regards, Andrijana Andrijana Radivojevic, PhD Associate Director, Pharmacometrics T +1 862 778-1152 M +1 917 714-1215 andrijana.radivojevic_at_novartis.com<mailto:andrijana.radivojevic_at_novartis.com> Novartis Pharmaceuticals Corporation One Health Plaza, 135/108A East Hanover, NJ 07936-1080 USA